
HIV Vaccine Industry Partnership Group
Case study 1: Strengthening industry engagement in HIV vaccine research and development
At AIDS 2022, the Vaccine group hosted a satellite to discuss barriers to industry involvement in HIV vaccine R&D, including recommendations for activating and optimizing industry participation in R&D. Watch the satellite session here and find the report here.

Case study 2: Biomarkers and clinical trial design
In 2022, the group hosted a workshop that explored how biomarkers could be used as surrogate markers of clinical efficacy in counterfactual vaccine trials. To access the workshop report, click here.

Co-chairs
Linda-Gail Bekker

Linda-Gail Bekker
Desmond Tutu HIV Centre Institute of Infectious Disease and Molecular Medicine, UCT Faculty of Health Sciences
South Africa
View
Civil society members
Industry members
Jerald C Sadoff

Jerald C Sadoff
Senior Advisor Vaccine Development, JRD Vaccine Therapeutic Area for Janssen R&D US, Johnson & Johnson
United States
View
Joseph G Joyce

Joseph G Joyce
Vaccine Process Research & Development, Merck & Co.
United States
View
Maria Grazia Pau

Maria Grazia Pau
Senior Director, Compound Development Team Leader for HIV vaccine programs, Janssen Pharmaceutical Companies of Johnson & Johnson
View
Romas Geleziunas

Romas Geleziunas
Executive Director in the Virology Department, Gilead Sciences
United States
View
Non-industry members
Susan Buchbinder

Susan Buchbinder
Department of Epidemiology & Biostatistics, School of Medicine, University of California, San Francisco
United States
View
Ralf Wagner

Ralf Wagner
Professor of Medical Microbiology (Virology), Institute of Medical Microbiology and Hygiene, University of Regensburg
Germany
View
Jean-Louis Excler

Jean-Louis Excler
International Vaccine Institute
Lao People's Democratic Republic
View
Tomáš Hanke

Tomáš Hanke
Professor of Vaccine Immunology, University of Oxford and a Distinguished Professor, Kumamoto University
Japan
View
William Schief

William Schief
The Scripps Research Institute’s Department of Immunology and Microbiology
United States
View
Devin Sok

Devin Sok
Vice President, Discovery and Innovation, International AIDS Vaccine Initiative
United States
View
Sangeetha Sagar

Sangeetha Sagar
Vice President, Product Development, International AIDS Vaccine Initiative
United States
View
Ex-officio – International AIDS Society
Carole Beilleau

Carole Beilleau
Director, Development and Partnerships
International AIDS Society
View
Julieta Firmat

Julieta Firmat
Associate Officer, HIV Programmes & Advocacy
International AIDS Society
View